Stifel analyst Jonathan Block lowered the firm’s price target on Align Technology (ALGN) to $275 from $285 and keeps a Buy rating on the shares. Q3 “offered few surprises,” but revenue fell “modestly below consensus,” notes the analyst, who expects the Street to prune 2025 top-line estimates following the report. However, the stock was weak into the print and at about 20-times the firm’s 2025 EPS estimate, “additional downside could prove limited,” the analyst added.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology price target lowered to $275 from $285 at Piper Sandler
- Align Technology price target lowered to $276 from $325 at Baird
- Align Technology sees Q4 revenue $995M-$1.015B, consensus $1.01B
- Align Technology introduces Invisalign Smile Architect
- Align Technology announces iTero intraoral scanner product innovations